Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: The Brisighella Heart Study

Journal of Hypertension

Volumn 30, Issue 3, 2012, Pages 492-496

  Cicero, Arrigo F G ^a   D'Addato, Sergio ^a   Veronesi, Maddalena ^a   Rosticci, Martina ^a   Santi, Francesca ^a   Dormi, Ada ^a   Borghi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

apolipoprotein B; blood pressure; cholesterolemia; relationship

Indexed keywords

APOLIPOPROTEIN B; CREATININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE PRESSURE; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84857048222     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834f6b11     Document Type: Conference Paper

References (24)

1. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Després JP. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study. Circulation 1996; 94:273-278. (Pubitemid 26266109)
2. Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, de Graaf J, Furberg CD. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes 2011; 4:337-345.
3. Ikeda K, Suzuki M, Ikebuchi M, Hara Y, Tsushima M, Yamamoto A, Harano Y. Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension. J Diabetes Complic 1995; 9:227-229.
4. Ryomoto KI, Suzuki M, Kanazawa A, Hasegawa M, Kimura Y, Yamamura T, Harano Y. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension. Am J Hypertens 2000; 13 (6 Pt 1):617-624. (Pubitemid 30461782)
5. Cekmen MB, Erbagci AB, Balat A, Duman C, Maral H, Ergen K, et al. Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clin Biochem 2003; 36:575-578. (Pubitemid 37244022)
6. de Carvalho EH, Filho Dde MB, Ximenes RA, de Albuquerque Mde F, de Melo HR, Gelenske T, et al. Prevalence of hyperapolipoprotein B and associations with other cardiovascular risk factors among human immunodeficiency virus-infected patients in Pernambuco, Brazil. Metab Syndr Relat Disord 2010; 8:403-410.
7. Cicero AFG, Bove M, Manca M, Borghi C, Gaddi AV. Detection of familial combined hyperlipoproteinemia patients in the Brisighella Heart Study historical cohort: an epidemiological approach. J Inherit Metab Dis 2007; 30:268. (Pubitemid 46488009)
8. Gaddi AV, Cicero AFG, Odoo FO, Poli A. Paoletti R on behalf of the Atherosclerosis and Metabolic Diseases Study Group. Practical guidelines for familial combined hyperlipidemia diagnosis: an update. Vasc Health Risk Manag 2007; 3:877-886.
9. Pei WD, Sun YH, Liu Q, Zheng WY, Zhang J, Zhang CY, et al. Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia. Int J Cardiol 2007; 115:293-296. (Pubitemid 46201712)
10. Descovich GC, Cavallo G, Mannino G, Lenzi S. The Brisighella survey: a study of dietary habits. Minerva Med 1983; 74:547-555. (Pubitemid 13128030)
11. ERICA Project Stuff. The CHD risk map of Europe. The 1st report of the WHO-ERICA Project. Eur Heart J 1988; 9:1-35.
12. Seccareccia F, Lanti M, Menotti A, Scanga M. Role of body mass index in the prediction of all cause mortality in over 62,000 men and women. The Italian RIFLE Pooling Project. Risk Factor and Life Expectancy. J Epidemiol Community Health 1988; 52:20-26.
13. Menotti A, Lanti M, Puddu PE, Carratelli L, Mancini M, Motolese M, et al. The risk functions incorporated in Riscard 2002: a software for the prediction of cardiovascular risk in the general population based on Italian data. Ital Heart J 2002; 3:114-121. (Pubitemid 34591554)
14. Menotti A, Lanti M, Agabiti-Rosei E, Carratelli L, Cavera G, Dormi A, et al. Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. Nutr Metab Cardiovasc Dis 2005; 15:426-440. (Pubitemid 43986478)
15. Ardigò D, Bernini F, Borghi C, Calandra S, Cicero AFG, Favari E, et al. on behalf of the ADSL project investigators. Advanced diagnostic support in lipidology project: role for phenotypic and functional evaluation of lipoproteins in dyslipidemias. Clin Lipidol 2010; 5:329-337.
16. Cicero AFG, Dormi A, D'Addato S, Borghi C, on behalf of the Brisighella Heart Study Staff. From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40years of the Brisighella Heart Study. Clin Lipidol 2011; 6:269-276.
17. Bonaa KH. Thelle DS: association between blood pressure and serum lipids in a population. The Tromso Study. Circulation 1991; 83:1305-1314.
18. Ruixing Y, Jinzhen W, Weixiong L, Yuming C, Dezhai Y, Shangling P. The environmental and genetic evidence for the association of hyperlipidemia and hypertension. J Hypertens 2009; 27:251-258.
19. Okosun IS, Choi S, Hash R, Dever GREA. Apolipoprotein B, ratio of total cholesterol to HDL-C, and blood pressure in abdominally obese white and black American women. J Hum Hypertens 2001; 15:299-305. (Pubitemid 32433023)
20. Borghi C, Veronesi M, Cosentino E, Cicero AF, Kuria F, Dormi A, Ambrosioni E. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure. J Hypertens 2007; 25:2051-2057. (Pubitemid 47476301)
21. Borghi G, Conficoni E, Cicero AFG. Role of the renin- angiotensinaldosterone system in the interaction between hypertension and lipid disorders. Eur Cardiovasc Dis 2009; 1:30-32.
22. Davidson MH. Apolipoprotein measurements: is more widespread use clinically indicated? Clin Cardiol 2009; 32:482-486.
23. Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 2010; 12:448-455.
24. Sata M, Fukuda D. Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J Med Invest 2010; 57:12-25.